Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김승현 | - |
dc.date.accessioned | 2019-11-30T18:23:33Z | - |
dc.date.available | 2019-11-30T18:23:33Z | - |
dc.date.issued | 2017-09 | - |
dc.identifier.citation | JOURNAL OF KOREAN MEDICAL SCIENCE, v. 32, no. 9, page. 1502-1507 | en_US |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2017.32.9.1502 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/115638 | - |
dc.description.abstract | Multiple sclerosis (MS) is a T-lymphocyte-mediated autoimmune disease that is characterized by inflammation in the central nervous system (CNS). Although many disease-modifying therapies (DMTs) are presumed effective in patients with MS, studies on the efficacy and safety of DMTs for preventing MS relapse are limited. Therefore, we tested the immunosuppressive anti-inflammatory effects of oral-formulated tacrolimus (FK506) on MS in a mouse model of experimental autoimmune encephalomyelitis (EAE). The mice were randomly divided into 3 experimental groups: an untreated EAE group, a low-dose tacrolimus-treated EAE group, and a high-dose tacrolimus-treated EAE group. After autoimmunization of the EAE mice with myelin oligodendrocyte glycoprotein, symptom severity scores, immunohistochemistry of the myelination of the spinal cord, and western blotting were used to evaluate the EAE mice. After the autoimmunization, the symptom scores of each EAE group significantly differed at times. The group treated with the larger tacrolimus dose had the lowest symptom scores. The tacrolimus-treated EAE groups exhibited less demyelination and inflammation and weak immunoreactivity for all of the immunization biomarkers. Our results revealed that oral-formulated tacrolimus inhibited the autoimmunization in MS pathogenesis by inactivating inflammatory cells. | en_US |
dc.description.sponsorship | This research was supported by the Chung-Ang University Graduate Research Scholarship (2016), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03936287). | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | en_US |
dc.subject | Multiple Sclerosis | en_US |
dc.subject | Neuromyelitis Optica | en_US |
dc.subject | Experimental Autoimmune Encephalomyelitis | en_US |
dc.subject | EAE | en_US |
dc.subject | Tacrolimus | en_US |
dc.subject | FK506 | en_US |
dc.title | The Anti-Inflammatory Effects of Oral-Formulated Tacrolimus in Mice with Experimental Autoimmune Encephalomyelitis | en_US |
dc.type | Article | en_US |
dc.relation.no | 9 | - |
dc.relation.volume | 32 | - |
dc.identifier.doi | 10.3346/jkms.2017.32.9.1502 | - |
dc.relation.page | 1502-1507 | - |
dc.relation.journal | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.contributor.googleauthor | Kim, Myung-Jin | - |
dc.contributor.googleauthor | Sung, Jung-Joon | - |
dc.contributor.googleauthor | Kim, Seung Hyun | - |
dc.contributor.googleauthor | Kim, Jeong-Min | - |
dc.contributor.googleauthor | Jeon, Gye Sun | - |
dc.contributor.googleauthor | Mun, Seog-Kyun | - |
dc.contributor.googleauthor | Ahn, Suk-Won | - |
dc.relation.code | 2017002851 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | kimsh1 | - |
dc.identifier.researcherID | T-5133-2017 | - |
dc.identifier.orcid | https://orcid.org/0000-0001-9644-9598 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.